The editor of the journal Neuropsychopharmacology, Charles Nemeroff, has resigned after failing to disclose financial ties to makers of a device he wrote a favorable review of.
Neuropsychopharmacology has published a correction citing Nemeroff's ties to the device maker and those of the article's other eight authors.
In addition to Nemeroff, seven of the authors were consultants to device maker Cyberonics. One of the article’s authors was an employee of the company.
The authors’ relationships to the company were first reported in The Wall Street Journal in July.
Neuropsychopharmacology published a review in July of the Cyberonics treatment, a small device implanted in the chest to deliver mild electrical pulses a nerve in the neck. The device is “a promising and well-tolerated intervention that is effective in a subset of patients with treatment-resistant depression,” the authors wrote.